Stay updated on TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added locations across the US (Arizona, California, Florida, Illinois, Kentucky, Michigan, New Hampshire, New York, North Carolina, Pennsylvania, Rhode Island, Texas, Wisconsin) and international sites (Bavaria, Chiba, Gunma, Ibaraki, Osaka, Tochigi, Toyama, Porto District, Setúbal District, Dolj, Middlesex, Scotland), and removed several previously listed locations along with the HHS Vulnerability Disclosure link.
    Difference
    1%
    Check dated 2025-12-19T12:56:32.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page footer revision label was updated from v3.3.1 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-28T06:45:52.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The Publications section now states that entries are automatically filled from PubMed with Revision: v3.3.1, replacing the previous wording about PubMed-generated lists (Revision: v3.2.0).
    Difference
    0.0%
    Check dated 2025-11-21T01:53:35.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The government funding notice warning was removed from the page. This note previously warned that information might not be up to date and inquiries could be delayed during funding lapses.
    Difference
    0.2%
    Check dated 2025-11-13T22:28:12.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The screenshots indicate only minor UI/layout refinements with no changes to core study content, such as objectives, eligibility, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-30T13:12:28.000Z thumbnail image
  9. Check
    89 days ago
    Change Detected
    Summary
    Core content updated with an operating-status notice and a version upgrade from v3.0.2 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-02T01:22:09.000Z thumbnail image

Stay in the know with updates to TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page.